TGFβ inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k)

Cell Proliferation

Volumn 42, Issue 1, 2009, Pages 1-9

  Montenegro, D E ^a   Franklin, T ^a   Moscinski, L C ^b,d   Zuckerman, K S ^c,d   Hu, X T ^a  

^a BARRY UNIVERSITY   (United States)

^b Division of Haematopathology and Laboratory Medicine

^c Division of Haematology and Medical Oncology

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOPRECIPITATION; METABOLISM; MYELOID LEUKEMIA; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA, MYELOID; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 58449087955     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00567.x     Document Type: Article

References (33)

1. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM (1993) TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009 1020.
2. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS (1986) Transforming growth factor-beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855 3860.
3. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A (1987) Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48, 417 428.
4. Agrotis A, Kalinina N, Bobik A (2005) Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr. Vasc Pharmacol. 3, 55 61.
5. Hu X, Moscinski LC, Zuckerman KS (1999) Transforming growth factor-β (TGFβ) inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at Ser795. Exp Hematol. 27, 605 614.
6. Nakao A, Roijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin CH et al 1997) Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway. J. Biol. Chem. 272, 2896 2900.
7. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215 1224.
8. Kyriakis JM, App H, Zhang X, Banerjee P, Brautigan DL, Rapp UR et al 1992) Raf-1 activates MAP kinase-kinase. Nature (Lond.) 358, 417 421.
9. Dent P, Hase W, Haystead TAJ, Vincent LA, Roberts TM, Sturgill TW (1992) Activation of mitogen-activated protein kinase kinase by v-raf in NIH3T3 cells and in vitro. Science (Washington DC) 257, 1404 1407.
10. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL (1993) A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science (Washington DC) 260, 315 319.
11. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90, 8319 8323.
12. Perkins GR, Marshall CJ, Collins MKL (1996) The role of MAP kinase kinase in Interleukin -3 stimulation of proliferation. Blood 87, 3669 3675.
13. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179 185.
14. Qiu M, Green SH (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9, 705 717.
15. Hu X, Moscinski LC, Valkov NI, Fisher AB, Hill BJ, Zuckerman KS (2000) Prolonged activation of the Mitogen-activated Protein Kinase pathway is required for macrophage-like differentiation of a Human Myeloid leukemic cell line. Cell Growth Differ. 11, 191 200.
16. Carroll MP, Clark-Iewis I, Rapp UR, May WS (1990) Interleukin 3 and granulocyte-macrophage colony stimulating factor mediate rapid phosphorylation and activation of cytosolic c-raf. J. Biol. Chem. 265, 19812 19817.
17. Kanakura Y, Druker B, Wood K, Mamon H, Okuda K, Roberts T et al 1991) GMCSF and IL-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line. Blood 77, 243 248.
18. Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD et al 1992) Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 79, 2880 2887.
19. Al-shami A, Naccache PH (1999) Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase. J. Biol. Chem. 274, 5333 5338.
20. Dhar-Mascareno M, Pedraza A, Golde DW (1993) PI3-kinase activation by GM-CSF in endothelium is upstream of Jak/Stat pathway: role of αGMR. BBRC 337 (551-556 2005.
21. Yonekura A, Osaki M, Hirota Y, Tsukazaki T, Miyazaki Y, Matsumoto T et al 1999) Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocr J. 46, 545 553.
22. Park HJ, Kim BC, Kim SJ, Choi KS (2002) Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Hepatology 35, 1360 1371.
23. Hayashida T, Decaestecker M, Schnaper HW (2003) Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 17, 1576 1578.
24. Ji Y, Lee HJ, Goodman C, Uskokovic M, Liby K, Sporn M et al 2006) The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells. Mol. Cancer Ther. 5, 1452 1458.
25. Halder SK, Beauchamp RD, Datta PK (2005) Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis. Exp Cell Res. 307, 231 246.
26. Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS (2001) Differential effects of transforming growth factor on the cell cycle regulatory molecules in human myeloid leukemia cells. Oncogene 20, 6840 6850.
27. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K et al 1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol. 140, 323 334.
28. Hu X, Moscinski LC, Hill BJ, Fisher AB, Zuckerman KS (1998) Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed event. Leukemia Res. 22, 817 826.
29. Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I et al 1987) Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 70, 192 199.
30. Reynisdottir I, Massague J (1997) The subcellular locations of p15ink4b and p27kip1 coordinate their inhibitory interactions with Cdk4 and cdk2. Genes Dev 11, 492 503.
31. Yi JY, Shin I, Arteaga CL (2005) Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J. Biol. Chem. 280, 10870 10876.
32. Whalen AM, Galasinski SG, Shapiro P, Nahreini TS, Ahn NG (1997) Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol. 17, 1947 1958.
33. Jinnin M, Ihn H, Tamaki K (2006) Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression. Mol. Pharmacol. 69, 597 607.